Stock Price Quote

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1461.80-29.75 (-1.99 %)
PREV CLOSE ( ) 1491.55
OPEN PRICE ( ) 1496.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 26276
TODAY'S LOW / HIGH ( )1444.00 1519.00
52 WK LOW / HIGH ( )1060.95 1757.65
NSE1463.90-27 (-1.81 %)
PREV CLOSE( ) 1490.90
OPEN PRICE ( ) 1497.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1463.90 (220)
VOLUME 1260734
TODAY'S LOW / HIGH( ) 1443.05 1517.90
52 WK LOW / HIGH ( )1052 1755.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-10 1949
Management Info
Premchand Godha - Chairman Pranay Godha - Managing Director
Registered Office

Address 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone 022- 66474444 / 62106050

Email ipca@ipca.com

Website www.ipca.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

27Jan Ipca Laboratories informs about board
Pursuant to Regulation 29 read with Regulation 47 of the Securities and..
08Jan Ipca Laboratories informs about compli
In Compliance with Regulation 74(5) of SEBI (Depositories and Participan..
03Jan IPCA Laboratories informs about change
IPCA Laboratories has informed that the Company has received communicati..
26Dec Ipca Laboratories informs about tradin
Ipca Laboratories has informed that the trading window for dealing in th..
05Dec Ipca Laboratories secures approval for
Ipca Laboratories has received necessary approval for voluntary closure..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit2675.65304.1
Gross Profit 3555.2 8221.6
Operating Profit 428513226.7
Net Sales 16626.861664.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE)
peergroup  2558.40 (2.61%)
M.Cap ( in Cr)31957.51
Coral Laboratories (BSE)
peergroup  807.60 (8.54%)
M.Cap ( in Cr)288.52
Vimta Labs (BSE)
peergroup  1119.70 (3.91%)
M.Cap ( in Cr)2488.29
Mercury Laboratories (BSE)
peergroup  849.00 (3.78%)
M.Cap ( in Cr)101.88
Aarti Drugs (BSE)
peergroup  410.85 (7.20%)
M.Cap ( in Cr)3749.83

Shareholding Pattern

NON-INSTITUTION 8.53%
FI/BANKS/INSURANCE 5.19%
PROMOTERS 44.72%
MUTUAL FUNDS/UTI 29.63%
GOVERNMENT 0%
FII 0%

About Ipca Laboratories Ltd.

Ipca Laboratories Ltd. was incorporated in the year 1949. Its today's share price is 1461.8. Its current market capitalisation stands at Rs 37086.48 Cr. In the latest quarter, company has reported Gross Sales of Rs. 61664.6 Cr and Total Income of Rs.62838.3 Cr. The company's management includes Prashant Godha, Swati Patankar, Narendra Mairpady, Kamal Kishore Seth, Pranay Godha, Ajit Kumar Jain, Premchand Godha, Harish P Kamath.

It is listed on the BSE with a BSE Code of 524494 , NSE with an NSE Symbol of IPCALAB and ISIN of INE571A01038. It's Registered office is at 48 , Kandivli Industrial Estate,Kandivli (West), Mumbai-400067, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are GM Kapadia & Co, Natvarlal Vepari & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.